Nkarta, Inc. (NKTX) stock
NKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.15−0.10 (-8.00%)
Close on Nov 18, 2026Market cap $82.37MP/E –Yield 0.00%
Nkarta revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nkarta's revenue for the twelve months ending Dec 31, 2019 was $115.00K. For fiscal 2025 it was $0.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0 | – |
| FY2024 | Dec 31, 2024 | $0 | -100.0% |
| FY2019 | Dec 31, 2019 | $115.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $2.31K | – |
See a number that looks wrong?